Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Different treatments for alopecia areata have unpredictable results and varying success rates.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Finasteride can cause a unique skin reaction on the penile shaft.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

New drug delivery systems improve treatment effectiveness and patient experience.

Sorafenib may cause hair loss in a way similar to alopecia areata.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.